Arcus Biosciences (RCUS) Invested Capital: 2017-2025
Historic Invested Capital for Arcus Biosciences (RCUS) over the last 8 years, with Sep 2025 value amounting to $534.0 million.
- Arcus Biosciences' Invested Capital fell 12.75% to $534.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $534.0 million, marking a year-over-year decrease of 12.75%. This contributed to the annual value of $533.0 million for FY2024, which is 15.37% up from last year.
- According to the latest figures from Q3 2025, Arcus Biosciences' Invested Capital is $534.0 million, which was down 17.34% from $646.0 million recorded in Q2 2025.
- Arcus Biosciences' Invested Capital's 5-year high stood at $842.0 million during Q4 2021, with a 5-year trough of $462.0 million in Q4 2023.
- In the last 3 years, Arcus Biosciences' Invested Capital had a median value of $579.0 million in 2025 and averaged $581.3 million.
- As far as peak fluctuations go, Arcus Biosciences' Invested Capital spiked by 372.70% in 2021, and later decreased by 29.68% in 2023.
- Arcus Biosciences' Invested Capital (Quarterly) stood at $842.0 million in 2021, then dropped by 21.97% to $657.0 million in 2022, then decreased by 29.68% to $462.0 million in 2023, then climbed by 15.37% to $533.0 million in 2024, then declined by 12.75% to $534.0 million in 2025.
- Its Invested Capital stands at $534.0 million for Q3 2025, versus $646.0 million for Q2 2025 and $579.0 million for Q1 2025.